{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:46:24Z","timestamp":1790959584305,"version":"4.1.0"},"reference-count":150,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Enteric infectious diseases account for more than a billion disease episodes yearly worldwide resulting in approximately 2 million deaths, with children under 5 years old and the elderly being disproportionally affected. Enteric pathogens comprise viruses, parasites, and bacteria; the latter including pathogens such as<jats:italic>Salmonella<\/jats:italic>[typhoidal (TS) and non-typhoidal (nTS)], cholera,<jats:italic>Shigella<\/jats:italic>and multiple pathotypes of<jats:italic>Escherichia coli<\/jats:italic>(<jats:italic>E. coli<\/jats:italic>). In addition, multi-drug resistant and extensively drug-resistant (XDR) strains (e.g.,<jats:italic>S.<\/jats:italic>Typhi H58 strain) of enteric bacteria are emerging; thus, renewed efforts to tackle enteric diseases are required. Many of these entero-pathogens could be controlled by oral or parenteral vaccines; however, development of new, effective vaccines has been hampered by lack of known immunological correlates of protection (CoP) and limited knowledge of the factors contributing to protective responses. To fully comprehend the human response to enteric infections, an invaluable tool that has recently re-emerged is the use of controlled human infection models (CHIMs) in which participants are challenged with virulent wild-type (wt) organisms. CHIMs have the potential to uncover immune mechanisms and identify CoP to enteric pathogens, as well as to evaluate the efficacy of therapeutics and vaccines in humans. CHIMs have been used to provide invaluable insights in the pathogenesis, host-pathogen interaction and evaluation of vaccines. Recently, several Oxford typhoid CHIM studies have been performed to assess the role of multiple cell types (B cells, CD8+ T, T<jats:sub>regs<\/jats:sub>, MAIT, Monocytes and DC) during<jats:italic>S<\/jats:italic>. Typhi infection. One of the key messages that emerged from these studies is that baseline antigen-specific responses are important in that they can correlate with clinical outcomes. Additionally, volunteers who develop typhoid disease (TD) exhibit higher levels and more activated cell types (e.g., DC and monocytes) which are nevertheless defective in discrete signaling pathways. Future critical aspects of this research will involve the study of immune responses to enteric infections at the site of entry, i.e., the intestinal mucosa. This review will describe our current knowledge of immunity to enteric fevers<jats:italic>caused by<\/jats:italic><jats:italic>S.<\/jats:italic>Typhi and<jats:italic>S.<\/jats:italic>Paratyphi A, with emphasis on the contributions of CHIMs to uncover the complex immunological responses to these organisms and provide insights into the determinants of protective immunity.<\/jats:p>","DOI":"10.3389\/fmicb.2022.983403","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T04:20:50Z","timestamp":1663647650000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Controlled human infectious models, a path forward in uncovering immunological correlates of protection: Lessons from enteric fevers studies"],"prefix":"10.3389","volume":"13","author":[{"given":"Marcelo B.","family":"Sztein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayaum S.","family":"Booth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,20]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1128\/JVI.78.5.2454-2459.2004","article-title":"Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens","volume":"78","author":"Aandahl","year":"2004","journal-title":"J. Virol."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1093\/phe\/phv026","article-title":"Ethical criteria for human challenge studies in infectious diseases","volume":"9","author":"Bambery","year":"2016","journal-title":"Public Health Ethics"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0022-1759(03)00265-5","article-title":"Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation","volume":"281","author":"Betts","year":"2003","journal-title":"J. Immunol. Methods"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1586\/14760584.5.4.505","article-title":"Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development","volume":"5","author":"Betts","year":"2006","journal-title":"Expert Rev. Vaccines"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1001\/jama.2009.1259","article-title":"Addressing the global disease burden of typhoid fever","volume":"302","author":"Bhutta","year":"2009","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3389\/fimmu.2015.00217","article-title":"Regulatory T-cells at the interface between human host and pathogens in infectious diseases and vaccination","volume":"6","author":"Boer","year":"2015","journal-title":"Front. Immunol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12967-020-02263-6","article-title":"Oral typhoid vaccine Ty21a elicits antigen-specific resident memory CD4(+) T cells in the human terminal ileum lamina propria and epithelial compartments","volume":"18","author":"Booth","year":"2020","journal-title":"J. Transl. Med."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/intimm\/dxy070","article-title":"Effect of the live oral attenuated typhoid vaccine, Ty21a, on systemic and terminal ileum mucosal CD4+ T memory responses in humans","volume":"31","author":"Booth","year":"","journal-title":"Int. Immunol."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1080\/21645515.2018.1564570","article-title":"Association between S. Typhi-specific memory CD4+ and CD8+ T responses in the terminal ileum mucosa and in peripheral blood elicited by the live oral typhoid vaccine Ty21a in humans","volume":"15","author":"Booth","year":"","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jcmgh.2017.08.002","article-title":"Systemic and terminal ileum mucosal immunity elicited by oral immunization with the Ty21a typhoid vaccine in humans","volume":"4","author":"Booth","year":"2017","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3389\/fimmu.2019.00424","article-title":"Attenuated oral typhoid vaccine Ty21a elicits lamina propria and intra-epithelial lymphocyte tissue-resident effector memory CD8 T responses in the human terminal ileum","volume":"10","author":"Booth","year":"","journal-title":"Front. Immunol."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3389\/fimmu.2015.00466","article-title":"Mucosal-associated invariant T cells in the human gastric mucosa and blood: role in Helicobacter pylori infection","volume":"6","author":"Booth","year":"2015","journal-title":"Front. Immunol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/vaccines9010024","article-title":"B and T cell immunity in tissues and across the ages","volume":"9","author":"Booth","year":"2021","journal-title":"Vaccines (Basel)."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1891852","article-title":"Intestinal and systemic inflammation induced by symptomatic and asymptomatic enterotoxigenic E. coli infection and impact on intestinal colonization and ETEC specific immune responses in an experimental human challenge model","volume":"13","author":"Brubaker","year":"2021","journal-title":"Gut Microbes"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1002\/hep.20454","article-title":"An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection","volume":"40","author":"Cabrera","year":"2004","journal-title":"Hepatology"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1139\/W10-025","article-title":"Intragastric immunization of mice with enterohemorrhagic Escherichia coli O157:H7 bacterial ghosts reduces mortality and shedding and induces a Th2-type dominated mixed immune response","volume":"56","author":"Cai","year":"2010","journal-title":"Can. J. Microbiol."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1128\/CVI.00617-15","article-title":"Characterization of mucosal immune responses to enterotoxigenic Escherichia coli vaccine antigens in a human challenge model: response profiles after primary infection and homologous rechallenge with strain H10407","volume":"23","author":"Chakraborty","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1093\/cid\/ciw145","article-title":"Single-dose live oral cholera vaccine CVD 103-HgR protects against human experimental infection with vibrio cholerae O1 El Tor","volume":"62","author":"Chen","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1086\/513990","article-title":"Clinical manifestations of plasmodium falciparum malaria experimentally induced by mosquito challenge","volume":"175","author":"Church","year":"1997","journal-title":"J. Infect. Dis."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e00988-19","DOI":"10.1128\/mSphere.00988-19","article-title":"Immune response characterization after controlled infection with lyophilized Shigella sonnei 53G","volume":"5","author":"Clarkson","year":"2020","journal-title":"mSphere"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e0012221","DOI":"10.1128\/mSphere.00122-21","article-title":"Shigella-specific immune profiles induced after parenteral immunization or oral challenge with either Shigella flexneri 2a or Shigella sonnei","volume":"6","author":"Clarkson","year":"2021","journal-title":"mSphere"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1080\/21645515.2019.1606971","article-title":"Serum IgG antibodies to Shigella lipopolysaccharide antigens: a correlate of protection against shigellosis","volume":"15","author":"Cohen","year":"2019","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1136\/gutjnl-2013-306253","article-title":"CCL20\/CCR6-mediated migration of regulatory T cells to the helicobacter pylori-infected human gastric mucosa","volume":"63","author":"Cook","year":"2014","journal-title":"Gut"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"574057","DOI":"10.3389\/fimmu.2020.574057","article-title":"Vi-vaccinations induce heterogeneous plasma cell responses that associate with protection from typhoid fever","volume":"11","author":"Cross","year":"2020","journal-title":"Front. Immunol."},{"key":"ref25","first-page":"346","article-title":"The global burden of typhoid fever","volume":"82","author":"Crump","year":"2004","journal-title":"Bull. World Health Organ."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1086\/649541","article-title":"Global trends in typhoid and paratyphoid fever","volume":"50","author":"Crump","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.3389\/fimmu.2019.02582","article-title":"IgA and IgG1 specific to Vi polysaccharide of Salmonella Typhi correlate with protection status in a typhoid fever controlled human infection model","volume":"10","author":"Dahora","year":"2019","journal-title":"Front. Immunol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/S1473-3099(15)00068-7","article-title":"Design, recruitment, and microbiological considerations in human challenge studies","volume":"15","author":"Darton","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/MOG.0000000000000021","article-title":"Typhoid epidemiology, diagnostics and the human challenge model","volume":"30","author":"Darton","year":"2014","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e0004926","DOI":"10.1371\/journal.pntd.0004926","article-title":"Using a human challenge model of infection to measure vaccine efficacy: a randomised, controlled trial comparing the typhoid vaccines M01ZH09 with placebo and Ty21a","volume":"10","author":"Darton","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1093\/cid\/cix042","article-title":"Evaluation of the clinical and microbiological response to Salmonella Paratyphi A infection in the first paratyphoid human challenge model","volume":"64","author":"Dobinson","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1128\/IAI.66.1.52-58.1998","article-title":"Effect of prior experimental human enteropathogenic Escherichia coli infection on illness following homologous and heterologous rechallenge","volume":"66","author":"Donnenberg","year":"1998","journal-title":"Infect. Immun."},{"key":"ref33","first-page":"667","article-title":"Studies of immunity in typhoid fever. Protection induced by killed oral antigens or by primary infection","volume":"44","author":"Dupont","year":"1971","journal-title":"Bull. World Health Organ."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1086\/518510","article-title":"Safety and clinical outcome of experimental challenge of human volunteers with plasmodium falciparum-infected mosquitoes: an update","volume":"196","author":"Epstein","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"e00416-20","DOI":"10.1128\/mSphere.00416-20","article-title":"Establishment of a controlled human infection model with a lyophilized strain of Shigella sonnei 53G","volume":"5","author":"Frenck","year":"2020","journal-title":"mSphere"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12967-016-0819-7","article-title":"Salmonella Typhi-specific multifunctional CD8+ T cells play a dominant role in protection from typhoid fever in humans","volume":"14","author":"Fresnay","year":"2016","journal-title":"J. Transl. Med."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3389\/fimmu.2017.00208","article-title":"Importance of salmonella Typhi-responsive CD8+ T cell immunity in a human typhoid fever challenge model","volume":"8","author":"Fresnay","year":"2017","journal-title":"Front. Immunol."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"e0008783","DOI":"10.1371\/journal.pntd.0008783","article-title":"Homologous and heterologous re-challenge with Salmonella Typhi and Salmonella Paratyphi A in a randomised controlled human infection model","volume":"14","author":"Gibani","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1093\/cid\/ciy670","article-title":"The impact of vaccination and prior exposure on stool shedding of Salmonella Typhi and salmonella Paratyphi in 6 controlled human infection studies","volume":"68","author":"Gibani","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/infdis\/136.6.717","article-title":"Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella Typhi as a liver oral vaccine","volume":"136","author":"Gilman","year":"1977","journal-title":"J. Infect. Dis."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1017\/S0950268800058088","article-title":"Infecting dose and severity of typhoid: analysis of volunteer data and examination of the influence of the definition of illness used","volume":"115","author":"Glynn","year":"1995","journal-title":"Epidemiol. Infect."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"4794","DOI":"10.1016\/j.vaccine.2019.01.003","article-title":"The way forward for ETEC controlled human infection models (CHIMs)","volume":"37","author":"Hanevik","year":"2019","journal-title":"Vaccine"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"e0145945","DOI":"10.1371\/journal.pone.0145945","article-title":"Differential killing of Salmonella enterica serovar Typhi by antibodies targeting Vi and lipopolysaccharide O:9 antigen","volume":"11","author":"Hart","year":"2016","journal-title":"PLoS One"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.3389\/fimmu.2020.01014","article-title":"MAIT cell activation and functions","volume":"11","author":"Hinks","year":"2020","journal-title":"Front. Immunol."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1056\/NEJM197009242831306","article-title":"Typhoid fever: pathogenesis and immunologic control","volume":"283","author":"Hornick","year":"1970","journal-title":"N. Engl. J. Med."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1086\/518138","article-title":"Woodward's legacy: from typhus to typhoid fever","volume":"45","author":"Hornick","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1016\/S0140-6736(17)32149-9","article-title":"Efficacy and immunogenicity of a vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial","volume":"390","author":"Jin","year":"2017","journal-title":"Lancet"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"e20201116","DOI":"10.1084\/jem.20201116","article-title":"Vi-specific serological correlates of protection for typhoid fever","volume":"218","author":"Jin","year":"2021","journal-title":"J. Exp. Med."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"e1001043","DOI":"10.1371\/journal.ppat.1001043","article-title":"Regulatory T cell suppressive potency dictates the balance between bacterial proliferation and clearance during persistent Salmonella infection","volume":"6","author":"Johanns","year":"2010","journal-title":"PLoS Pathog."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"S596","DOI":"10.1093\/cid\/ciz909","article-title":"Consensus report on Shigella controlled human infection model: immunological assays","volume":"69","author":"Kaminski","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"155","DOI":"10.12688\/wellcomeopenres.14909.1","article-title":"Controlled human malaria infection in semi-immune Kenyan adults (CHMI-SIKA): a study protocol to investigate in vivo Plasmodium falciparum malaria parasite growth in the context of pre-existing immunity","volume":"3","author":"Kapulu","year":"2018","journal-title":"Wellcome Open Res."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.4049\/jimmunol.1102809","article-title":"Phenotypic analysis of pneumococcal polysaccharide-specific B cells","volume":"188","author":"Khaskhely","year":"2012","journal-title":"J. Immunol."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1600-065X.2008.00689.x","article-title":"Humoral and cell-mediated immunity to the intracellular pathogen Francisella tularensis","volume":"225","author":"Kirimanjeswara","year":"2008","journal-title":"Immunol. Rev."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1093\/cid\/cit454","article-title":"Lack of homologous protection against campylobacter jejuni CG8421 in a human challenge model","volume":"57","author":"Kirkpatrick","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/S0140-6736(87)91316-X","article-title":"Protective activity of Vi capsular polysaccharide vaccine against typhoid fever","volume":"2","author":"Klugman","year":"1987","journal-title":"Lancet"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"5806","DOI":"10.1128\/IAI.67.11.5806-5810.1999","article-title":"Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam","volume":"67","author":"Kossaczka","year":"1999","journal-title":"Infect. Immun."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/0264-410X(95)00102-7","article-title":"A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity","volume":"13","author":"Kotloff","year":"1995","journal-title":"Vaccine"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1084\/jem.20022020","article-title":"Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen","volume":"197","author":"Kruetzmann","year":"2003","journal-title":"J. Exp. Med."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jaut.2018.08.007","article-title":"A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity","volume":"95","author":"Kumar","year":"2018","journal-title":"J. Autoimmun."},{"key":"ref60","first-page":"1114","article-title":"Typhoid fever vaccines","volume-title":"Plokin\u2019s Vaccines","author":"Levine","year":"2018"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/infdis\/133.4.424","article-title":"Attenuated, streptomycin-dependent Salmonella typhi oral vaccine: potential deleterious effects of lyophilization","volume":"133","author":"Levine","year":"1976","journal-title":"J. Infect. Dis."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S0140-6736(87)90480-6","article-title":"Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation","volume":"1","author":"Levine","year":"1987","journal-title":"Lancet"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/ni0504-460","article-title":"Vaccine development strategies for improving immunization: the role of modern immunology","volume":"5","author":"Levine","year":"2004","journal-title":"Nat. Immunol."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/S1286-4579(01)01487-3","article-title":"Host-salmonella interaction: human trials","volume":"3","author":"Levine","year":"2001","journal-title":"Microbes Infect."},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1056\/NEJM200104263441701","article-title":"The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children","volume":"344","author":"Lin","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref66","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/iai.64.1.10-15.1996","article-title":"Factors influencing secondary vibriocidal immune responses: relevance for understanding immunity to cholera","volume":"64","author":"Losonsky","year":"1996","journal-title":"Infect. Immun."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1128\/IAI.71.4.1755-1762.2003","article-title":"Helicobacter pylori-specific CD4+ CD25 high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals","volume":"71","author":"Lundgren","year":"2003","journal-title":"Infect. Immun."},{"key":"ref68","doi-asserted-by":"publisher","first-page":"S577","DOI":"10.1093\/cid\/ciz886","article-title":"Consensus report on Shigella controlled human infection model: introduction and overview","volume":"69","author":"MacLennan","year":"","journal-title":"Clin. Infect. Dis."},{"key":"ref69","doi-asserted-by":"publisher","first-page":"S591","DOI":"10.1093\/cid\/ciz891","article-title":"Consensus report on Shigella controlled human infection model: clinical endpoints","volume":"69","author":"MacLennan","year":"","journal-title":"Clin. Infect. Dis."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1084\/jem.192.2.237","article-title":"Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo","volume":"192","author":"Mastroeni","year":"2000","journal-title":"J. Exp. Med."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1751-7915.2011.00316.x","article-title":"Rectal single dose immunization of mice with Escherichia coli O157:H7 bacterial ghosts induces efficient humoral and cellular immune responses and protects against the lethal heterologous challenge","volume":"5","author":"Mayr","year":"2012","journal-title":"Microb. Biotechnol."},{"key":"ref72","doi-asserted-by":"publisher","first-page":"e1004914","DOI":"10.1371\/journal.ppat.1004914","article-title":"Activation of salmonella Typhi-specific regulatory T cells in typhoid disease in a wild-type S. Typhi challenge model","volume":"11","author":"McArthur","year":"2015","journal-title":"PLoS Pathog."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"e38408","DOI":"10.1371\/journal.pone.0038408","article-title":"Heterogeneity of multifunctional IL-17A producing S. Typhi-specific CD8+ T cells in volunteers following Ty21a typhoid immunization","volume":"7","author":"McArthur","year":"2012","journal-title":"PLoS One"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of mice and not men: differences between mouse and human immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J. Immunol."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.virol.2015.03.032","article-title":"Live attenuated vaccines: historical successes and current challenges","author":"Minor","year":"2015","journal-title":"Virology"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/cid\/civ295","article-title":"Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study","volume":"61","author":"Mohan","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref77","first-page":"638","article-title":"Vaxchora: the first FDA-approved cholera vaccination in the United States","volume":"42","author":"Mosley","year":"2017","journal-title":"P T."},{"key":"ref78","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nri.2015.3","article-title":"Tissue-resident memory T cells: local specialists in immune defence","volume":"16","author":"Mueller","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"ref79","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/s41590-018-0133-z","article-title":"Clonal analysis of Salmonella-specific effector T cells reveals serovar-specific and cross-reactive T cell responses","volume":"19","author":"Napolitani","year":"2018","journal-title":"Nat. Immunol."},{"key":"ref80","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1093\/infdis\/156.6.974","article-title":"Experimental human infections with Giardia lamblia","volume":"156","author":"Nash","year":"1987","journal-title":"J. Infect. Dis."},{"key":"ref81","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1164\/rccm.201401-0128OC","article-title":"Density and duration of pneumococcal carriage is maintained by transforming growth factor beta1 and T regulatory cells","volume":"189","author":"Neill","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"S155","DOI":"10.1093\/cid\/ciaa370","article-title":"Early insights from clinical trials of typhoid conjugate vaccine","volume":"71","author":"Neuzil","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref83","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/j.1462-5822.2006.00694.x","article-title":"Dendritic cells in the recognition of intestinal microbiota","volume":"8","author":"Niess","year":"2006","journal-title":"Cell. Microbiol."},{"key":"ref84","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1093\/infdis\/jiw030","article-title":"Oral typhoid vaccination with live-attenuated salmonella Typhi strain Ty21a generates Ty21a-responsive and heterologous influenza virus-responsive CD4+ and CD8+ T cells at the human intestinal mucosa","volume":"213","author":"Pennington","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref85","doi-asserted-by":"publisher","first-page":"e2642","DOI":"10.1371\/journal.pntd.0002642","article-title":"Predicting the impact of vaccination on the transmission dynamics of typhoid in South Asia: a mathematical modeling study","volume":"8","author":"Pitzer","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref86","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1093\/cid\/cis238","article-title":"Nomenclature for immune correlates of protection after vaccination","volume":"54","author":"Plotkin","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref87","doi-asserted-by":"publisher","first-page":"e22663","DOI":"10.1371\/journal.pone.0022663","article-title":"Outer membrane protein A (OmpA) of Shigella flexneri 2a, induces protective immune response in a mouse model","volume":"6","author":"Pore","year":"2011","journal-title":"PLoS One"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"4814","DOI":"10.1016\/j.vaccine.2019.03.051","article-title":"Clinical endpoints for efficacy studies","volume":"37","author":"Porter","year":"2019","journal-title":"Vaccine"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"6813","DOI":"10.1016\/j.vaccine.2017.05.068","article-title":"Developing and utilizing controlled human models of infection","volume":"35","author":"Porter","year":"2017","journal-title":"Vaccine"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1084\/jem.20062363","article-title":"Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses","volume":"204","author":"Precopio","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref91","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S0140-6736(21)01124-7","article-title":"Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial","volume":"398","author":"Qadri","year":"2021","journal-title":"Lancet"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1002\/cyto.b.20554","article-title":"Elucidation of seventeen human peripheral blood B-cell subsets and quantification of the tetanus response using a density-based method for the automated identification of cell populations in multidimensional flow cytometry data","author":"Qian","year":"2010","journal-title":"Cytometry B Clin. Cytom."},{"key":"ref93","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/srep00216","article-title":"Multifunctional CD4 T cell responses in patients with active tuberculosis","volume":"2","author":"Qiu","year":"2012","journal-title":"Sci. Rep."},{"key":"ref94","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.0300-9475.2004.01447.x","article-title":"Antigen-specific in vitro suppression of murine Helicobacter pylori-reactive immunopathological T cells by CD4CD25 regulatory T cells","volume":"60","author":"Raghavan","year":"2004","journal-title":"Scand. J. Immunol."},{"key":"ref95","doi-asserted-by":"publisher","first-page":"e1178","DOI":"10.1002\/cti2.1178","article-title":"Human Salmonella Typhi exposure generates differential multifunctional cross-reactive T-cell memory responses against Salmonella Paratyphi and invasive nontyphoidal Salmonella","volume":"9","author":"Rapaka","year":"2020","journal-title":"Clin. Transl. Immunol."},{"key":"ref96","doi-asserted-by":"publisher","first-page":"e312","DOI":"10.1016\/S1473-3099(18)30177-4","article-title":"Experimental infection of human volunteers","volume":"18","author":"Roestenberg","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref97","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3389\/fimmu.2019.00257","article-title":"Age-associated heterogeneity of Ty21a-induced T cell responses to HLA-E restricted Salmonella Typhi antigen presentation","volume":"10","author":"Rudolph","year":"","journal-title":"Front. Immunol."},{"key":"ref98","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/intimm\/dxz011","article-title":"Diversity of Salmonella Typhi-responsive CD4 and CD8 T cells before and after Ty21a typhoid vaccination in children and adults","volume":"31","author":"Rudolph","year":"","journal-title":"Int. Immunol."},{"key":"ref99","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.clim.2019.04.002","article-title":"Characteristics of regulatory T-cell populations before and after Ty21a typhoid vaccination in children and adults","volume":"203","author":"Rudolph","year":"","journal-title":"Clin. Immunol."},{"key":"ref100","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1146\/annurev-immunol-042718-041717","article-title":"Regulatory T cells and human disease","volume":"38","author":"Sakaguchi","year":"2020","journal-title":"Annu. Rev. Immunol."},{"key":"ref101","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1093\/intimm\/dxp095","article-title":"Regulatory T cells: how do they suppress immune responses?","volume":"21","author":"Sakaguchi","year":"2009","journal-title":"Int. Immunol."},{"key":"ref102","doi-asserted-by":"publisher","first-page":"5852","DOI":"10.4049\/jimmunol.173.9.5852","article-title":"Identification of a human HLA-E-restricted CD8+ T cell subset in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine","volume":"173","author":"Salerno-Goncalves","year":"2004","journal-title":"J. Immunol."},{"key":"ref103","doi-asserted-by":"publisher","first-page":"104572","DOI":"10.1016\/j.cellimm.2022.104572","article-title":"Mucosal-associated invariant T cells exhibit distinct functional signatures associated with protection against typhoid fever","volume":"378","author":"Salerno-Goncalves","year":"2022","journal-title":"Cell. Immunol."},{"key":"ref104","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3389\/fimmu.2017.00398","article-title":"Challenge of humans with wild-type Salmonella enterica serovar Typhi elicits changes in the activation and homing characteristics of mucosal-associated invariant T cells","volume":"8","author":"Salerno-Goncalves","year":"2017","journal-title":"Front. Immunol."},{"key":"ref105","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.4049\/jimmunol.169.4.2196","article-title":"Characterization of CD8(+) effector T cell responses in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine","volume":"169","author":"Salerno-Goncalves","year":"2002","journal-title":"J. Immunol."},{"key":"ref106","doi-asserted-by":"publisher","first-page":"728685","DOI":"10.3389\/fimmu.2021.728685","article-title":"B cells control mucosal-associated invariant T cell responses to Salmonella enterica serovar Typhi infection through the CD85j HLA-G receptor","volume":"12","author":"Salerno-Goncalves","year":"2021","journal-title":"Front. Immunol."},{"key":"ref107","doi-asserted-by":"publisher","first-page":"e5879","DOI":"10.1371\/journal.pone.0005879","article-title":"Priming of Salmonella enterica serovar Typhi-specific CD8(+) T cells by suicide dendritic cell cross-presentation in humans","volume":"4","author":"Salerno-Goncalves","year":"2009","journal-title":"PLoS One"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.vaccine.2019.10.020","article-title":"Differential functional patterns of memory CD4(+) and CD8(+) T-cells from volunteers immunized with Ty21a typhoid vaccine observed using a recombinant Escherichia coli system expressing S. Typhi proteins","volume":"38","author":"Salerno-Goncalves","year":"2020","journal-title":"Vaccine"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1128\/IAI.73.6.3521-3530.2005","article-title":"Immunization of volunteers with Salmonella enterica serovar Typhi strain Ty21a elicits the oligoclonal expansion of CD8+ T cells with predominant Vbeta repertoires","volume":"73","author":"Salerno-Goncalves","year":"2005","journal-title":"Infect. Immun."},{"key":"ref110","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1128\/CVI.00234-10","article-title":"Ex vivo kinetics of early and long-term multifunctional human leukocyte antigen E-specific CD8+ cells in volunteers immunized with the Ty21a typhoid vaccine","volume":"17","author":"Salerno-Goncalves","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"ref111","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.4049\/jimmunol.170.5.2734","article-title":"Concomitant induction of CD4+ and CD8+ T cell responses in volunteers immunized with Salmonella enterica serovar Typhi strain CVD 908-htrA","volume":"170","author":"Salerno-Goncalves","year":"2003","journal-title":"J. Immunol."},{"key":"ref112","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.smim.2007.12.006","article-title":"Phenotypic and functional heterogeneity of human memory B cells","volume":"20","author":"Sanz","year":"2008","journal-title":"Semin. Immunol."},{"key":"ref113","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.imlet.2013.12.001","article-title":"Cross-presentation by human dendritic cell subsets","volume":"158","author":"Segura","year":"2014","journal-title":"Immunol. Lett."},{"key":"ref114","doi-asserted-by":"publisher","first-page":"101429","DOI":"10.1016\/j.smim.2020.101429","article-title":"Human challenge trials in vaccine development","volume":"50","author":"Sekhar","year":"2020","journal-title":"Semin. Immunol."},{"key":"ref115","doi-asserted-by":"publisher","first-page":"e1561","DOI":"10.1016\/S2214-109X(21)00346-6","article-title":"Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial","volume":"9","author":"Shakya","year":"2021","journal-title":"Lancet Glob. Health"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2147\/VDT.S23634","article-title":"The utility of human challenge studies in vaccine development: lessons learned from cholera","volume":"2011","author":"Shirley","year":"2011","journal-title":"Vaccine (Auckl)."},{"key":"ref117","doi-asserted-by":"publisher","first-page":"4008","DOI":"10.4049\/jimmunol.1100718","article-title":"Vigorous response of human innate functioning IgM memory B cells upon infection by Neisseria gonorrhoeae","volume":"188","author":"So","year":"2012","journal-title":"J. Immunol."},{"key":"ref118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1462-5822.2003.00336.x","article-title":"Immunity to Salmonella from a dendritic point of view","volume":"6","author":"Sundquist","year":"2004","journal-title":"Cell. Microbiol."},{"key":"ref119","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1086\/518140","article-title":"Cell-mediated immunity and antibody responses elicited by attenuated Salmonella enterica serovar Typhi strains used as live oral vaccines in humans","volume":"45","author":"Sztein","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref120","doi-asserted-by":"publisher","first-page":"a029546","DOI":"10.1101\/cshperspect.a029546","article-title":"Is a human CD8 T-cell vaccine possible, and if so, what would it take? CD8 T-cell-mediated protective immunity and vaccination against enteric bacteria","volume":"10","author":"Sztein","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref121","doi-asserted-by":"publisher","first-page":"13581","DOI":"10.1038\/s41598-020-70492-2","article-title":"Salmonella enterica serovar Typhi exposure elicits ex vivo cell-type-specific epigenetic changes in human gut cells","volume":"10","author":"Sztein","year":"2020","journal-title":"Sci. Rep."},{"key":"ref122","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3389\/fimmu.2014.00516","article-title":"Complex adaptive immunity to enteric fevers in humans: lessons learned and the path forward","volume":"5","author":"Sztein","year":"2014","journal-title":"Front. Immunol."},{"key":"ref123","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.4049\/jimmunol.155.8.3987","article-title":"Cytotoxic T lymphocytes after oral immunization with attenuated vaccine strains of Salmonella typhi in humans","volume":"155","author":"Sztein","year":"1995","journal-title":"J. Immunol."},{"key":"ref124","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1093\/infdis\/170.6.1508","article-title":"Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi","volume":"170","author":"Sztein","year":"1994","journal-title":"J. Infect. Dis."},{"key":"ref125","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1093\/infdis\/166.4.837","article-title":"Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR","volume":"166","author":"Tacket","year":"1992","journal-title":"J. Infect. Dis."},{"key":"ref126","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0035-9203(95)90667-3","article-title":"Extension of the volunteer challenge model to study South American cholera in a population of volunteers predominantly with blood group antigen O","volume":"89","author":"Tacket","year":"1995","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref127","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1093\/infdis\/162.2.550","article-title":"Challenge studies in volunteers using Escherichia coli strains with diffuse adherence to HEp-2 cells","volume":"162","author":"Tacket","year":"1990","journal-title":"J. Infect. Dis."},{"key":"ref128","doi-asserted-by":"publisher","first-page":"103310","DOI":"10.1016\/j.ebiom.2021.103310","article-title":"Human challenge study with a Shigella bioconjugate vaccine: analyses of clinical efficacy and correlate of protection","volume":"66","author":"Talaat","year":"2021","journal-title":"EBioMedicine"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"S580","DOI":"10.1093\/cid\/ciz892","article-title":"Consensus report on Shigella controlled human infection model: conduct of studies","volume":"69","author":"Talaat","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref130","doi-asserted-by":"publisher","first-page":"732","DOI":"10.7150\/ijms.7768","article-title":"Paratyphoid fever: splicing the global analyses","volume":"11","author":"Teh","year":"2014","journal-title":"Int. J. Med. Sci."},{"key":"ref131","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1128\/CVI.00532-10","article-title":"The Vi conjugate typhoid vaccine is safe, elicits protective levels of IgG anti-Vi, and is compatible with routine infant vaccines","volume":"18","author":"Thiem","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"ref132","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.it.2015.05.003","article-title":"Emerging concepts in tissue-resident T cells: lessons from humans","volume":"36","author":"Thome","year":"2015","journal-title":"Trends Immunol."},{"key":"ref133","doi-asserted-by":"publisher","first-page":"e0003837","DOI":"10.1371\/journal.pntd.0003837","article-title":"Oral wild-type salmonella Typhi challenge induces activation of circulating monocytes and dendritic cells in individuals who develop typhoid disease","volume":"9","author":"Toapanta","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref134","doi-asserted-by":"publisher","first-page":"e0004766","DOI":"10.1371\/journal.pntd.0004766","article-title":"Oral challenge with wild-type Salmonella Typhi induces distinct changes in B cell subsets in individuals who develop typhoid disease","volume":"10","author":"Toapanta","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref135","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/B978-0-12-811924-2.00029-8","article-title":"Induction of local and systemic immunity by Salmonella Typhi in humans","volume-title":"Mucosal Vaccines","author":"Toapanta","year":"2020"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"11653","DOI":"10.1038\/ncomms11653","article-title":"MAIT cells are activated during human viral infections","volume":"7","author":"van Wilgenburg","year":"2016","journal-title":"Nat. Commun."},{"key":"ref137","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/imr.12085","article-title":"Role of regulatory T cells during virus infection","volume":"255","author":"Veiga-Parga","year":"2013","journal-title":"Immunol. Rev."},{"key":"ref138","doi-asserted-by":"publisher","first-page":"3680","DOI":"10.1128\/IAI.67.7.3680-3685.1999","article-title":"Mucosal and systemic immune responses in humans after primary and booster immunizations with orally administered invasive and noninvasive live attenuated bacteria","volume":"67","author":"Viret","year":"1999","journal-title":"Infect. Immun."},{"key":"ref139","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1093\/cid\/ciu078","article-title":"An outpatient, ambulant-design, controlled human infection model using escalating doses of Salmonella Typhi challenge delivered in sodium bicarbonate solution","volume":"58","author":"Waddington","year":"","journal-title":"Clin. Infect. Dis."},{"key":"ref140","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jinf.2014.01.006","article-title":"Advancing the management and control of typhoid fever: a review of the historical role of human challenge studies","volume":"68","author":"Waddington","year":"","journal-title":"J. Infect."},{"key":"ref141","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.clim.2010.11.006","article-title":"Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD-S. Typhi-specific IgA and IgG B memory cells in humans","volume":"138","author":"Wahid","year":"2011","journal-title":"Clin. Immunol."},{"key":"ref142","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.vaccine.2006.10.040","article-title":"Cell-mediated immune responses in humans after immunization with one or two doses of oral live attenuated typhoid vaccine CVD 909","volume":"25","author":"Wahid","year":"2007","journal-title":"Vaccine"},{"key":"ref143","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/mi.2008.30","article-title":"Generation of specific effector and memory T cells with gut- and secondary lymphoid tissue- homing potential by oral attenuated CVD 909 typhoid vaccine in humans","volume":"1","author":"Wahid","year":"2008","journal-title":"Mucosal Immunol."},{"key":"ref144","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1128\/CVI.00058-12","article-title":"Live oral typhoid vaccine Ty21a induces cross-reactive humoral immune responses against Salmonella enterica serovar Paratyphi A and S. Paratyphi B in humans","volume":"19","author":"Wahid","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"ref145","doi-asserted-by":"publisher","first-page":"6624","DOI":"10.4049\/jimmunol.178.10.6624","article-title":"A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus","volume":"178","author":"Wei","year":"2007","journal-title":"J. Immunol."},{"key":"ref146","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/nm0604-570","article-title":"When are research risks reasonable in relation to anticipated benefits?","volume":"10","author":"Weijer","year":"2004","journal-title":"Nat. Med."},{"key":"ref147","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1016\/j.carres.2003.07.008","article-title":"Immunology of bacterial polysaccharide antigens","volume":"338","author":"Weintraub","year":"2003","journal-title":"Carbohydr. Res."},{"key":"ref148","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/imm.12673","article-title":"The role of mucosal-associated invariant T cells in infectious diseases","volume":"150","author":"Wong","year":"2017","journal-title":"Immunology"},{"key":"ref149","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/0035-9203(80)90133-9","article-title":"Volunteer studies of typhoid fever and vaccines","volume":"74","author":"Woodward","year":"1980","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref150","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1128\/IAI.67.3.1338-1346.1999","article-title":"Potent immunoregulatory effects of Salmonella typhi flagella on antigenic stimulation of human peripheral blood mononuclear cells","volume":"67","author":"Wyant","year":"1999","journal-title":"Infect. Immun."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.983403\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T16:53:18Z","timestamp":1676825598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.983403\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,20]]},"references-count":150,"alternative-id":["10.3389\/fmicb.2022.983403"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2022.983403","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,20]]},"article-number":"983403"}}